Headline

The latest stories from AHA Today.

The 988 Suicide and Crisis Lifeline last week announced that georouting, a process which routs cellphone calls to 988 contact centers based on the caller’s approximate location, began last week with two major U.S. wireless carriers, that, together, make up nearly half of all wireless calls to 988.
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at community pharmacies.
The Department of Health and Human Services Sept. 29 declared a public health emergency for North Carolina due to health impacts from Hurricane Helene after making similar declarations for Florida and Georgia.
Johnson & Johnson Sept. 30 notified the Health Resources and Services Administration that it is ceasing implementation of its proposed 340B rebate model.
The Centers for Medicare & Medicaid Services Sept. 27 announced that average premiums, benefits and plan choices for Medicare Advantage and Part D will remain stable for 2025.
In this conversation, Brenda Romero, administrator at Presbyterian Española Hospital, discusses the methods for accessing treatment and the importance of the hospital's innovative and community-focused work.
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a family member getting a respiratory virus infection this fall and winter.
The Department of Health and Human Services’ Office of Inspector General Sept. 24 recommended that additional oversight is needed to ensure that remote patient monitoring in Medicare is being used and billed appropriately, according to a report.
The Health Resources and Services Administration Sept. 27 sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month. 
AHA's newest social media toolkit for encouraging vaccination against the flu and COVID-19 focuses on receiving the latest vaccines before peak respiratory virus season begins.